Washington, D.C., (December 4, 2018) —MedStar Heart in partnership with CardioCell has been approved to conduct an investigational new drug clinical trial, called STEMVAD at MedStar Heart & Vascular Institute. The goal of this study is to determine whether stem cell therapy improves myocardial function in patients with severe heart failure. “Innovative therapies to improve heart function and outcomes of patients with advanced heart failure are sorely needed,” said Selma Mohammed, MD, PhD. Read more.
Recent Posts
- Five MedStar Health Researchers Awarded Funding through Associate Giving Campaign
Hyattsville, MD—MedStar Health Research Institute has awarded five early-career investigators desi... - MedStar Health Research Institute Awarded Research Grant from the U.S. Department of Defense
Hyattsville, MD — Suzanne Groah, MD, MSPH, has been awarded a contract through the U.S. Departmen... - MedStar Investigators Evaluate Validity and Reliability of Diabetes Survival Skills Knowledge Test
MedStar Health investigators examined the validity and reliability of the KNOW Diabetes test, a surv...
Contact
Eva Hochberger
Communications & Planning Manager
Phone: 301-560-2917
[email protected]